TALPHERA, INC. Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)
TALPHERA, INC. (TLPH) had Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) of $2.00 thousand as of 2013-03-31, per its 10-Q filed 2013-05-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 · last filed 2013-05-08
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $2.00K.
- 2012-06-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $3.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) |
|---|---|
| 2013-03-31 | $2.00K 10-Q · filed 2013-05-08 |
| 2012-06-30 | $3.00K 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |